Events

Upcoming Events

January 30, 2008 (6:00 - 9:00 PM)

San Diego, California

From Physics to Pharma, New Tools and Protocols to Maximize Phase I Clinical Trials

Ali Arjomand, Ph.D.

Accium BioSciences

American Society of Clinical Pharmacology & Therapeutics (ASCPT)

2008 Annual Meeting

April 2-5, 2008

Orlando, Florida

Exhibit Booth #206

Past Events

Applied Pharmaceutical Analysis 2007

Sponsored by the Boston Society for Advanced Therapeutics

September 17-21, 2007

The Conference Center at Harvard Medical

Boston, MA

Ali Arjomand, Ph.D.

Accium BioSciences

Overcoming Challenging ADME Studies: When and Where to Apply Accelerator Mass Spectrometry

July 18, 2007 Session IV 9:00 AM - 12:00 PM

Human radiolabeled studies provide a broad understanding of the distribution and metabolism of novel compounds. Traditional liquid scintillation methods often provide the required detection for these studies. In certain studies, however, the amount of radioisotope in the samples falls below the reliable detection limit of liquid scintillation counting. This can occur if (1) the administered dose is in the microgram range, (2) the bioavailability is low, (3) the compound has low specific activity, and (4) there is a need to lower the radiolabel exposure to study subjects. In such cases, Accelerator Mass Spectrometry (AMS) is employed to overcome current detection limits, expanding the detection range to well below that of any other bioanalytical platform

20th Annual Symposium of the US Central Chapter of the International Isotope Society

2007 Annual Meeting

September 27-28, 2007

The Cincinnati Marriot Airport

Hebron, KY

Ugo Zoppi, Ph.D.

Director, AMS Laboratories

Accium BioSciences

Microdosing & Phase 0: to Predict Failure and Success

World Pharmaceutical Congress (CHI Conference)

June 12-13, 2007

Pennsylvania Convention Center

Philadelphia, PA

Ali Arjomand, Ph.D.

Accium BioSciences

Recent Experience with Conducting Microdosing Studies in the US

June 12, 2007 3:05-3:35 PM

From Discovery to IND (IBC Conference)

Scientific Strategies and Processes to Improve Your Chances of Success

March 13-14, 2007

Sheraton Inner Harbor, Baltimore, USA

Ali Arjomand, Ph.D.

Accium BioSciences

Exploratory IND Studies – From Theory to Practice

March 13, 2007 10:05-10:30 AM

Strategically implemented, Exploratory IND studies can help bring better drug candidates into Phase 1 development. The key ingredients for conducting such studies are now available to US researchers, including agency guidance and encouragement. In this hands-on, practical presentation, the nuts and bolts of conducting such studies in the US will be discussed. Case studies based on the microdosing protocol will be provided.